Is myopathy a side effect of KLOR-CON ? ( FactMed.com )

About this FactMed analysis covering adverse side effect reports of KLOR-CON patients who developed myopathy.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 45 individuals taking KLOR-CON reported myopathy to the FDA. A total of 6455 KLOR-CON drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between KLOR-CON and myopathy. In doing so, we compare KLOR-CON with other drugs that cause myopathy, to help you evaluate whether or not KLOR-CON causes myopathy. Likewise, this page shows the most highly-reported side effects of KLOR-CON, so you can see if myopathy ranks among KLOR-CON's most well-known side effects.

Summary Statistics
Reports of KLOR-CON causing myopathy: 45
Reports of any side effect of KLOR-CON : 6455
Percentage of KLOR-CON patients where myopathy is a reported side effect: 0.6971%

FDA reports of any drug causing myopathy : 3605
Average percentage for all medicated patients where myopathy is reported as a complication: 0.0226%

Physician opinion on KLOR-CON as adverse event culprit:

Overall opinion for all reports of this drug:

Most frequent diagnoses/indications for prescribing KLOR-CON:

PRODUCT USED FOR UNKNOWN INDICATION ( 271 patients )
MINERAL SUPPLEMENTATION ( 228 patients )
DRUG USE FOR UNKNOWN INDICATION ( 217 patients )
BLOOD POTASSIUM DECREASED ( 125 patients )
ELECTROLYTE SUBSTITUTION THERAPY ( 86 patients )
BLOOD POTASSIUM ( 83 patients )
SUPPLEMENTATION THERAPY ( 66 patients )
HYPOKALAEMIA ( 60 patients )
PROPHYLAXIS ( 43 patients )
HYPERTENSION ( 43 patients )
MUSCLE SPASMS ( 21 patients )
CARDIAC DISORDER ( 16 patients )
CARDIAC FAILURE CONGESTIVE ( 10 patients )
DIURETIC THERAPY ( 9 patients )
NUTRITIONAL SUPPORT ( 9 patients )
FLUID RETENTION ( 9 patients )
BLOOD PRESSURE ( 8 patients )
SWELLING ( 8 patients )
BLOOD POTASSIUM ABNORMAL ( 6 patients )
SUBSTITUTION THERAPY ( 5 patients )
ELECTROLYTE IMBALANCE ( 5 patients )
MEDICAL DIET ( 4 patients )
VITAMIN SUPPLEMENTATION ( 3 patients )
MYOCARDIAL INFARCTION ( 3 patients )
CARDIOVASCULAR EVENT PROPHYLAXIS ( 3 patients )
DRUG EXPOSURE DURING PREGNANCY ( 3 patients )
ROUTINE HEALTH MAINTENANCE ( 3 patients )
GOUT ( 2 patients )
RENAL DISORDER ( 2 patients )
ATRIAL FIBRILLATION ( 2 patients )
DRUG THERAPY ( 2 patients )
SURGERY ( 2 patients )
OEDEMA ( 2 patients )
CHEST PAIN ( 2 patients )
PULMONARY HYPERTENSION ( 2 patients )
HYPOKALAEMIC SYNDROME ( 2 patients )
BLOOD CALCIUM ( 2 patients )
LIVER DISORDER ( 2 patients )
OEDEMA PERIPHERAL ( 2 patients )
POLYURIA ( 1 patients )
HYPOCALCAEMIA ( 1 patients )
CEREBROVASCULAR ACCIDENT ( 1 patients )
ILL-DEFINED DISORDER ( 1 patients )
BLOOD CHOLESTEROL INCREASED ( 1 patients )
DYSPEPSIA ( 1 patients )
BLOOD ELECTROLYTES ABNORMAL ( 1 patients )
FAMILIAL PERIODIC PARALYSIS ( 1 patients )
GITELMAN'S SYNDROME ( 1 patients )
PARALYSIS ( 1 patients )
HYPOGLYCAEMIA ( 1 patients )
ARTHRITIS ( 1 patients )
BLOOD COUNT ABNORMAL ( 1 patients )
MYASTHENIA GRAVIS ( 1 patients )
EXTRASYSTOLES ( 1 patients )
BLOOD PRESSURE ABNORMAL ( 1 patients )
( 0 patients )

Drugs with high FDA adverse event association with myopathy:

LIPITOR (517 patients)
ZOCOR (480 patients)
ASPIRIN (474 patients)
SIMVASTATIN (410 patients)
FOSAMAX (309 patients)
PREDNISONE (241 patients)
CRESTOR (239 patients)
ZOMETA (201 patients)
PREDNISOLONE (199 patients)
LASIX (177 patients)
FUROSEMIDE (162 patients)
ZETIA (153 patients)
HYDROCHLOROTHIAZIDE (144 patients)
PREDNISONE TAB (139 patients)
LEVOTHYROXINE SODIUM (138 patients)
VIOXX (130 patients)
ALLOPURINOL (125 patients)
DEXAMETHASONE (124 patients)
INSULIN (120 patients)
COUMADIN (118 patients)
CYCLOSPORINE (113 patients)
ATENOLOL (112 patients)
ATORVASTATIN CALCIUM (110 patients)
NORVASC (108 patients)
CLARITHROMYCIN (107 patients)
AMBIEN (104 patients)
MYCOPHENOLATE MOFETIL (103 patients)
LISINOPRIL (99 patients)
NOROXIN (98 patients)
DECADRON (97 patients)
OMEPRAZOLE (97 patients)
POTASSIUM CHLORIDE (96 patients)
SORAFENIB (RAF KINASE INHIBITOR) (95 patients)
GABAPENTIN (94 patients)
SYNTHROID (94 patients)
LAMIVUDINE (90 patients)
AMLODIPINE (90 patients)
RAMIPRIL (89 patients)
NEXIUM (88 patients)
PRILOSEC (87 patients)
METHYLPREDNISOLONE (85 patients)
WARFARIN SODIUM (83 patients)
ZIDOVUDINE (82 patients)
ALBUTEROL (82 patients)
LANSOPRAZOLE (80 patients)
MEK INHIBITOR (DIHYDROXYPROP-DIFLU-METHOXYPHEN-CYCLOPROPA-SULFAMI) (80 patients)
PROTONIX (79 patients)
ACETAMINOPHEN (77 patients)
FOLIC ACID (77 patients)
MULTI-VITAMINS (75 patients)
XANAX (75 patients)
COZAAR (73 patients)
NEURONTIN (73 patients)
REMICADE (71 patients)
REVLIMID (69 patients)
HUMIRA (68 patients)
AMIODARONE HCL (67 patients)
FLONASE (65 patients)
CELEXA (64 patients)
FERROUS SULFATE TAB (64 patients)
ATORVASTATIN (64 patients)
AMLODIPINE BESYLATE (64 patients)
SPIRONOLACTONE (63 patients)
MAGNEVIST (62 patients)
VYTORIN (62 patients)
ZOLOFT (61 patients)
PEPCID (60 patients)
PROGRAF (60 patients)
CITALOPRAM HYDROBROMIDE (59 patients)
VICODIN (59 patients)
ADVAIR DISKUS 100/50 (59 patients)
ULTRAVIST 150 (59 patients)
PLAVIX (59 patients)
METHOTREXATE (58 patients)
COLCHICINE (58 patients)
AREDIA (57 patients)
OXYCONTIN (57 patients)
LYRICA (57 patients)
DIDANOSINE (56 patients)
ENALAPRIL MALEATE (55 patients)
HEPARIN SODIUM INJECTION (55 patients)
TAMOXIFEN CITRATE (55 patients)
ACYCLOVIR (52 patients)
FENOFIBRATE (52 patients)
PRAVASTATIN (52 patients)
CLONAZEPAM (51 patients)
ITRACONAZOLE (51 patients)
CYCLOPHOSPHAMIDE (51 patients)
DIGOXIN (49 patients)
SEBIVO (49 patients)
TOPROL-XL (49 patients)
LORAZEPAM (48 patients)
DILTIAZEM (48 patients)
LORTAB (48 patients)
ELAVIL (47 patients)
DIFLUCAN (47 patients)
METOPROLOL TARTRATE (46 patients)
ATIVAN (46 patients)
VELCADE (45 patients)
ALENDRONATE SODIUM (45 patients)
VITAMIN D (45 patients)
KLOR-CON (45 patients)
PRAVACHOL (45 patients)
WELLBUTRIN (44 patients)
TRICOR (44 patients)
DARVOCET-N 100 (44 patients)
PERCOCET (44 patients)
RAPAMUNE (43 patients)
ASCORBIC ACID (43 patients)
LEVAQUIN (43 patients)
AROMASIN (43 patients)
DIAZEPAM (43 patients)
ZANTAC (43 patients)
GEMFIBROZIL (41 patients)
CELEBREX (41 patients)
OXYCODONE HCL (41 patients)
ABACAVIR (40 patients)
LEXAPRO (40 patients)
NIFEDIPINE (40 patients)
RADIATION THERAPY (39 patients)
ACETYLSALICYLIC ACID SRT (39 patients)
ACIPHEX (39 patients)
METFORMIN HCL (39 patients)
IRON (39 patients)
ALTACE (39 patients)
TACROLIMUS (38 patients)
EFAVIRENZ (38 patients)
ZYPREXA (38 patients)
ZYRTEC (38 patients)
LESCOL (37 patients)
[THERAPY UNSPECIFIED] (37 patients)
METOPROLOL (37 patients)
GLEEVEC (37 patients)
PANTOPRAZOLE SODIUM (36 patients)
FOSAMAX PLUS D (36 patients)
PROPRANOLOL HYDROCHLORIDE (36 patients)
EFFEXOR (36 patients)
AMIODARONE (36 patients)
CEFTRIAXONE (36 patients)
HERCEPTIN (35 patients)
THALIDOMIDE (35 patients)
FUSIDIC ACID (35 patients)
SINGULAIR (35 patients)
IBUPROFEN (35 patients)
SPIRIVA (35 patients)
LOSARTAN POTASSIUM (35 patients)
VANCOMYCIN (35 patients)
WARFARIN (34 patients)
PERIDEX (34 patients)
BISOPROLOL (34 patients)
HYZAAR (34 patients)
SIROLIMUS (34 patients)
SOLU-MEDROL (34 patients)
ALPRAZOLAM (34 patients)
CO-TRIMOXAZOLE (34 patients)
AMITRIPTYLINE HCL (34 patients)
COREG (34 patients)
VITAMINS (UNSPECIFIED) (33 patients)
ACETYLSALICYLIC ACID (33 patients)
AZATHIOPRINE (33 patients)
ZOFRAN (33 patients)
CALTRATE +D (33 patients)
PROTEINASE INHIBITORS (33 patients)
CARTIA /USA/ (33 patients)
NIASPAN (33 patients)
PANTOPRAZOLE (33 patients)
MEGESTROL ACETATE (32 patients)
COMPAZINE (32 patients)
ADENOSINE (32 patients)
ALDACTONE (32 patients)
LANTUS (32 patients)
GASMOTIN (32 patients)
PROZAC (32 patients)
ARIMIDEX (31 patients)
AVELOX (31 patients)
FENTANYL (31 patients)
CALCIUM (UNSPECIFIED) (31 patients)
PAXIL (31 patients)
GLIPIZIDE (31 patients)
FLUCONAZOLE (31 patients)
ARANESP (31 patients)
CLARITIN (31 patients)
DILAUDID (31 patients)
NEUPOGEN (31 patients)
AVANDIA (31 patients)
B12 ^RECIP^ (30 patients)
K-DUR (30 patients)
CALCIUM CARBONATE (30 patients)
CELLCEPT (30 patients)
METFORMIN (30 patients)
CLOPIDOGREL (30 patients)
TRAMADOL HCL (30 patients)
REQUIP (29 patients)
CARVEDILOL (29 patients)
GLUCOPHAGE (29 patients)
FLOMAX (29 patients)
ZESTRIL (29 patients)
MIRTAZAPINE (29 patients)
TIAZAC (29 patients)
CAPECITABINE (29 patients)
KETEK (29 patients)
NICORANDIL (29 patients)
VERAPAMIL (29 patients)
CYMBALTA (28 patients)
RALTEGRAVIR (28 patients)
LOVASTATIN (28 patients)
CALCIUM (28 patients)
ACTOS (28 patients)
MICARDIS (28 patients)
DILTIAZEM HYDROCHLORIDE (28 patients)

Most common side effects for patients taking KLOR-CON:

DYSPNOEA (881 patients)
PAIN (840 patients)
NAUSEA (744 patients)
CARDIAC FAILURE CONGESTIVE (725 patients)
FATIGUE (684 patients)
ASTHENIA (654 patients)
ANXIETY (640 patients)
DIZZINESS (605 patients)
OEDEMA PERIPHERAL (601 patients)
PNEUMONIA (596 patients)
CHEST PAIN (565 patients)
HYPERTENSION (554 patients)
FALL (551 patients)
ANAEMIA (522 patients)
DIARRHOEA (522 patients)
HEADACHE (484 patients)
BACK PAIN (477 patients)
DEPRESSION (477 patients)
VOMITING (469 patients)
INJURY (450 patients)
ATRIAL FIBRILLATION (433 patients)
ARTHRALGIA (374 patients)
HYPOTENSION (373 patients)
PAIN IN EXTREMITY (366 patients)
DEHYDRATION (365 patients)
RENAL FAILURE (364 patients)
WEIGHT DECREASED (361 patients)
CONSTIPATION (347 patients)
MYOCARDIAL INFARCTION (344 patients)
ABDOMINAL PAIN (324 patients)
URINARY TRACT INFECTION (313 patients)
OSTEOARTHRITIS (307 patients)
OSTEONECROSIS OF JAW (303 patients)
EMOTIONAL DISTRESS (297 patients)
CEREBROVASCULAR ACCIDENT (294 patients)
INSOMNIA (294 patients)
ECONOMIC PROBLEM (294 patients)
PYREXIA (290 patients)
GASTROOESOPHAGEAL REFLUX DISEASE (289 patients)
WEIGHT INCREASED (283 patients)
DRUG INEFFECTIVE (273 patients)
CHRONIC OBSTRUCTIVE PULMONARY DISEASE (273 patients)
COUGH (272 patients)
BLOOD GLUCOSE INCREASED (262 patients)
MALAISE (259 patients)
BONE DISORDER (255 patients)
DEATH (254 patients)
HYPOAESTHESIA (252 patients)
RENAL FAILURE ACUTE (251 patients)
GAIT DISTURBANCE (250 patients)
CONFUSIONAL STATE (246 patients)
HYPOKALAEMIA (240 patients)
CARDIOMEGALY (240 patients)
DYSPHAGIA (238 patients)
BRONCHITIS (238 patients)
DECREASED APPETITE (232 patients)
PARAESTHESIA (230 patients)
SYNCOPE (226 patients)
SPINAL OSTEOARTHRITIS (222 patients)
PLEURAL EFFUSION (220 patients)
INFECTION (219 patients)
CORONARY ARTERY DISEASE (219 patients)
RASH (218 patients)
DIABETES MELLITUS (217 patients)
ANHEDONIA (217 patients)
MUSCLE SPASMS (214 patients)
NEUROPATHY PERIPHERAL (214 patients)
MITRAL VALVE INCOMPETENCE (213 patients)
PAIN IN JAW (209 patients)
CONTUSION (206 patients)
MUSCULOSKELETAL PAIN (206 patients)
DEEP VEIN THROMBOSIS (200 patients)
ATELECTASIS (195 patients)
MULTIPLE INJURIES (195 patients)
OEDEMA (194 patients)
RESPIRATORY FAILURE (192 patients)
OSTEOMYELITIS (191 patients)
OSTEONECROSIS (190 patients)
INTERVERTEBRAL DISC DEGENERATION (186 patients)
ARTHRITIS (185 patients)
PULMONARY EMBOLISM (182 patients)
MYALGIA (180 patients)
ABDOMINAL PAIN UPPER (175 patients)
SEPSIS (174 patients)
PALPITATIONS (173 patients)
BRADYCARDIA (173 patients)
CONDITION AGGRAVATED (172 patients)
CELLULITIS (172 patients)
SOMNOLENCE (168 patients)
CARDIOMYOPATHY (167 patients)
HYPERLIPIDAEMIA (166 patients)
ASTHMA (164 patients)
DEFORMITY (163 patients)
PULMONARY HYPERTENSION (162 patients)
CHOLELITHIASIS (161 patients)
CHEST DISCOMFORT (161 patients)
DYSPNOEA EXERTIONAL (158 patients)
PRURITUS (158 patients)
FEELING ABNORMAL (156 patients)
TOOTH EXTRACTION (153 patients)
SINUSITIS (153 patients)
SWELLING (152 patients)
ERYTHEMA (152 patients)
BALANCE DISORDER (149 patients)
TREMOR (149 patients)
HYPERHIDROSIS (148 patients)
LOSS OF CONSCIOUSNESS (146 patients)
HYPOPHAGIA (146 patients)
CATARACT (145 patients)
ARTERIOSCLEROSIS (142 patients)
MUSCULAR WEAKNESS (142 patients)
BONE PAIN (141 patients)
PANCYTOPENIA (141 patients)
CARDIAC DISORDER (141 patients)
NECK PAIN (139 patients)
SLEEP APNOEA SYNDROME (136 patients)
SPINAL COLUMN STENOSIS (136 patients)
CARDIAC FAILURE (135 patients)
DENTAL CARIES (135 patients)
TRANSIENT ISCHAEMIC ATTACK (134 patients)
BLOOD PRESSURE INCREASED (134 patients)
HAEMOGLOBIN DECREASED (134 patients)
JOINT SWELLING (133 patients)
ABASIA (131 patients)
ABDOMINAL DISTENSION (129 patients)
INTERVERTEBRAL DISC PROTRUSION (129 patients)
RIB FRACTURE (129 patients)
HEART RATE INCREASED (126 patients)
ARRHYTHMIA (125 patients)
RENAL FAILURE CHRONIC (124 patients)
THERAPEUTIC AGENT TOXICITY (123 patients)
HIATUS HERNIA (122 patients)
GASTRITIS (121 patients)
VISION BLURRED (121 patients)
TRICUSPID VALVE INCOMPETENCE (121 patients)
THROMBOCYTOPENIA (120 patients)
VERTIGO (120 patients)
UPPER RESPIRATORY TRACT INFECTION (120 patients)
HAEMORRHOIDS (119 patients)
METASTASES TO BONE (119 patients)
TACHYCARDIA (118 patients)
MULTIPLE MYELOMA (118 patients)
INTERNATIONAL NORMALISED RATIO INCREASED (116 patients)
HEART RATE IRREGULAR (116 patients)
OSTEOPENIA (115 patients)
EXOSTOSIS (114 patients)
LUNG INFILTRATION (112 patients)
GENERAL PHYSICAL HEALTH DETERIORATION (111 patients)
UNEVALUABLE EVENT (111 patients)
CARDIAC MURMUR (111 patients)
LUNG NEOPLASM (109 patients)
SURGERY (109 patients)
OBESITY (109 patients)
DYSPEPSIA (109 patients)
THROMBOSIS (109 patients)
TYPE 2 DIABETES MELLITUS (107 patients)
BLOOD CREATININE INCREASED (107 patients)
MEMORY IMPAIRMENT (105 patients)
FLUID RETENTION (103 patients)
CARDIAC ARREST (102 patients)
BONE LESION (102 patients)
DECREASED INTEREST (101 patients)
HYPONATRAEMIA (100 patients)
MENTAL STATUS CHANGES (99 patients)
HYPERKALAEMIA (99 patients)
NERVOUSNESS (99 patients)
OSTEOPOROSIS (97 patients)
BLOOD POTASSIUM DECREASED (97 patients)
ARTHROPATHY (97 patients)
HYPOXIA (97 patients)
SPINAL COMPRESSION FRACTURE (95 patients)
BLOOD CHOLESTEROL INCREASED (95 patients)
AMNESIA (95 patients)
MOUTH ULCERATION (95 patients)
GASTROINTESTINAL HAEMORRHAGE (94 patients)
ANGINA PECTORIS (94 patients)
FLUSHING (93 patients)
RENAL DISORDER (93 patients)
CHILLS (92 patients)
HERPES ZOSTER (91 patients)
HAEMATOCHEZIA (91 patients)
NEOPLASM MALIGNANT (91 patients)
ABDOMINAL DISCOMFORT (90 patients)
DIVERTICULUM INTESTINAL (90 patients)
PRESYNCOPE (90 patients)
TOOTHACHE (90 patients)
VISUAL ACUITY REDUCED (89 patients)
SWELLING FACE (89 patients)
DISCOMFORT (89 patients)
BLOOD UREA INCREASED (88 patients)
HAEMORRHAGE (87 patients)
PRIMARY SEQUESTRUM (86 patients)
LUMBAR SPINAL STENOSIS (86 patients)
SCOLIOSIS (85 patients)
LETHARGY (85 patients)
OSTEOSCLEROSIS (85 patients)
RENAL CYST (84 patients)
DRUG INTERACTION (84 patients)
STOMATITIS (84 patients)
CONVULSION (83 patients)
IMPAIRED HEALING (83 patients)
VENTRICULAR EXTRASYSTOLES (83 patients)
PLATELET COUNT DECREASED (82 patients)
OVERDOSE (82 patients)
NEPHROLITHIASIS (82 patients)
WHEEZING (82 patients)
RADICULOPATHY (81 patients)
OSTEITIS (81 patients)
MUSCULOSKELETAL STIFFNESS (81 patients)
URTICARIA (80 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.

Recent FactMed Activity for KLOR-CON

Issue	Description / Topic	Timestamp
QUESTION ASTHMA	Having trouble finding trigger for my asthma attacks. Saw report on potassium being possible trigger. Has anyone found this to be so.	2015-07-22 09:40:12
QUESTION URINARY TRACT INFECTION	I have been taking KLOR-CON M20 since 2/22/16 one and one-half tablets daily and this week I developed blisters on my tongue and the next day I had a very bad urinary track infection . I stopped the medication and the blisters went away but I still have the urinary tract infection.	2016-05-06 22:28:49
QUESTION OTOTOXICITY	Ototoxity and kl or Kong?	2016-06-28 21:45:13
QUESTION DRY MOUTH	does this drug cause dry mouth	2016-07-07 08:29:48
QUESTION DRY MOUTH	does klor con cause severe dry mouth	2016-07-07 08:30:57
QUESTION ABNORMAL WEIGHT GAIN	Can klor-con help start asthma problem	2016-09-26 11:51:32
QUESTION GENITAL BURNING SENSATION	I just started on the generic for Klor-Con and have only used 2 of my Potassium CL 10MEG ER tablets and I had a burning sensation when I urinated. Is this unusual or not. I have just gotten over a bladder infection three weeks ago.	2016-12-04 16:47:16
QUESTION ABDOMINAL PAIN	Fine fuglehus..og hadde mamma hatt sÃ¥nt "boss" liggende, skulle eg gjerne tatt imot ;) det er ellers blitt fyllt opp av hauger med gammelt rusk&rask her hos oss de siste dagene..en stadig stÃ¸rre del av mine foreldres flyttelass finner nemlig veien hjem til loftet mitt. Jammen godt jeg ikke har innnedningsplarer for de rommene med det fÃ¸rste ;)Knallfine hvitveisbilder under her.Og spÃ¸rs om du ikkje mÃ¥ stille inn GPS'en pÃ¥ mali-mo heimen snart og ta et kaffislaberas ;)	2017-03-20 08:29:33
QUESTION ABDOMINAL PAIN UPPER	- Love these Ann, yov1;82&7#ue captured so much atmosphere and the shot of the bridesmaid covering her eyes and chatting to the two grown ups with her back to camera is beautiful. I’ve missed my 10th but if you fancy recreating Bali in another 10 and including big flip flops and kneeling we’re on.May 29, 2012 – 11:56 am	2017-03-20 08:45:35
QUESTION NECK PAIN	Hi there, I found your web site via Google at the same time as looking for a related matter, your site got here up, it seems to be good. I have bormeaokkd it in my google bookmarks.	2017-03-20 08:47:11
QUESTION INTERVERTEBRAL DISC DEGENERATION	Mi tam siÄ™ Å›piew Kazika a jeszcze bardziej gra Kultu podoba. Co on tam mÃ³wi to staram siÄ™ nie braÄ‡ do serca, zwÅ‚aszcza to o piraceniu jego pÅ‚yt. Ciekawe co na opiniÄ™ Autora odpowie Toyah, ktÃ³ry zadaje mi siÄ™ lubi Kazika prnneajmziyj jako Å›piewaka.	2017-03-20 08:55:24
QUESTION ARTHRITIS	Do you have a spam issue on this website; I also am a blogger, and I was wanting to know your situation; many of us have developed some nice practices and we are looking to trade solutions with other folks, why not shoot me an email if ineedtster.	2017-03-20 08:56:33
QUESTION CORONARY ARTERY DISEASE	Greetings from Ohio! I’m bored to death at work so I decided to check out your website on my iphone during lunch break. I love the inotamrfion you present here and can’t wait to take a look when I get home. I’m surprised at how quick your blog loaded on my phone .. I’m not even using WIFI, just 3G .. Anyways, awesome site!	2017-03-20 09:08:46

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about myopathy and KLOR-CON, post it here. You may receive a response from a fellow patient - or a leading expert in the field.

Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking KLOR-CON, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.

Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in KLOR-CON. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.

We are currently accepting registration for KLOR-CON experts. If you are a healthcare provider experienced in prescribing KLOR-CON, please register here.